|
US4196265A
(en)
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
|
US4172124A
(en)
|
1978-04-28 |
1979-10-23 |
The Wistar Institute |
Method of producing tumor antibodies
|
|
US4608337A
(en)
|
1980-11-07 |
1986-08-26 |
The Wistar Institute |
Human hybridomas and the production of human monoclonal antibodies by human hybridomas
|
|
US4701409A
(en)
|
1984-11-15 |
1987-10-20 |
The Wistar Institute |
Detection of B-cell neoplasms
|
|
US4693975A
(en)
|
1984-11-20 |
1987-09-15 |
The Wistar Institute |
Human hybridroma fusion partner for production of human monoclonal antibodies
|
|
US5015568A
(en)
|
1986-07-09 |
1991-05-14 |
The Wistar Institute |
Diagnostic methods for detecting lymphomas in humans
|
|
US5202429A
(en)
|
1986-07-09 |
1993-04-13 |
The Wistar Institute |
DNA molecules having human BCL-2 gene sequences
|
|
US5198338A
(en)
|
1989-05-31 |
1993-03-30 |
Temple University |
Molecular probing for human t-cell leukemia and lymphoma
|
|
US5149628A
(en)
|
1989-11-15 |
1992-09-22 |
Temple University |
Methods for detecting bcl-3 gene in human leukemias
|
|
US6040140A
(en)
|
1991-12-11 |
2000-03-21 |
Thomas Jefferson University |
Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities
|
|
US5633135A
(en)
|
1991-12-11 |
1997-05-27 |
Thomas Jefferson University |
Chimeric nucleic acids and proteins resulting from ALL-1 region chromosome abnormalities
|
|
WO1993012136A1
(en)
|
1991-12-11 |
1993-06-24 |
Thomas Jefferson University |
Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region
|
|
US5674682A
(en)
|
1992-10-29 |
1997-10-07 |
Thomas Jefferson University |
Nucleic acid primers for detecting micrometastasis of prostate cancer
|
|
EP0667920B1
(en)
|
1992-10-29 |
2003-01-15 |
Thomas Jefferson University |
Methods of detecting micrometastasis of prostate cancer
|
|
US7175995B1
(en)
|
1994-10-27 |
2007-02-13 |
Thomas Jefferson University |
TCL-1 protein and related methods
|
|
US5985598A
(en)
|
1994-10-27 |
1999-11-16 |
Thomas Jefferson University |
TCL-1 gene and protein and related methods and compositions
|
|
US5695944A
(en)
|
1995-05-05 |
1997-12-09 |
Thomas Jefferson University |
Modulation of bcl-2 phosphorylation
|
|
US5567586A
(en)
|
1995-05-18 |
1996-10-22 |
Thomas Jefferson University |
Methods of indentifying solid tumors with chromosome abnormalities in the ALL-1 region
|
|
US5928884A
(en)
|
1996-02-09 |
1999-07-27 |
Croce; Carlo M. |
FHIT proteins and nucleic acids and methods based thereon
|
|
US6242212B1
(en)
|
1996-02-09 |
2001-06-05 |
Thomas Jefferson University |
Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
|
|
WO1998035707A1
(en)
|
1997-02-18 |
1998-08-20 |
Thomas Jefferson University |
Compositions that bind to pancreatic cancer cells and methods of using the same
|
|
AU6951098A
(en)
|
1997-04-04 |
1998-10-30 |
The Texas A & M University System |
Noninvasive detection of colonic biomarkers using fecal messenger rna
|
|
EP1098968A4
(en)
|
1998-07-20 |
2002-01-02 |
Univ Jefferson |
NITRILASE APPROVALS
|
|
US6255293B1
(en)
|
1998-07-24 |
2001-07-03 |
Yeda Research And Development Co., Ltd. |
Prevention of metastasis with 5-aza-2′-deoxycytidine
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
EP1165586A4
(en)
|
1999-03-15 |
2003-05-28 |
Univ Jefferson |
TCL-1B GENES AND PROTEINS AND RELATED METHODS AND METHODS
|
|
US6579857B1
(en)
|
1999-06-11 |
2003-06-17 |
Evanston Northwestern Healthcare Research Institute |
Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
|
|
US7163801B2
(en)
|
1999-09-01 |
2007-01-16 |
The Burnham Institute |
Methods for determining the prognosis for cancer patients using tucan
|
|
US6891031B2
(en)
|
2000-02-18 |
2005-05-10 |
The Regents Of The University Of California |
Coordinate cytokine regulatory sequences
|
|
US20010026796A1
(en)
|
2000-03-14 |
2001-10-04 |
Croce Carlo M. |
TCL1 enhances Akt kinase activity and mediates its nuclear translocation
|
|
CA2406366A1
(en)
|
2000-04-11 |
2001-10-18 |
Thomas Jefferson University |
Muir-torre-like syndrome infhit deficient mice
|
|
US20020086331A1
(en)
|
2000-05-16 |
2002-07-04 |
Carlo Croce |
Crystal structure of worm NitFhit reveals that a Nit tetramer binds two Fhit dimers
|
|
US7060811B2
(en)
|
2000-10-13 |
2006-06-13 |
Board Of Regents, The University Of Texas System |
WWOX: a tumor suppressor gene mutated in multiple cancers
|
|
US20040033502A1
(en)
|
2001-03-28 |
2004-02-19 |
Amanda Williams |
Gene expression profiles in esophageal tissue
|
|
US20050176025A1
(en)
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)
|
|
EP2428570B1
(en)
|
2001-09-28 |
2018-05-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
|
US7371736B2
(en)
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
|
GB0128898D0
(en)
|
2001-12-03 |
2002-01-23 |
Biotech Res Ventures Pte Ltd |
Materials and methods relating to the stabilization and activation of a tumour suppressor protein
|
|
CA2478065C
(en)
|
2002-03-08 |
2013-01-08 |
Eisai Co. Ltd. |
Macrocyclic compounds useful as pharmaceuticals
|
|
EP1496928A4
(en)
|
2002-04-08 |
2005-08-10 |
Ciphergen Biosystems Inc |
SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA
|
|
CA2484920A1
(en)
|
2002-04-29 |
2003-11-13 |
Thomas Jefferson University |
Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
|
|
AU2003273542A1
(en)
|
2002-05-31 |
2003-12-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of identifying and isolating stem cells and cancer stem cells
|
|
US20050260639A1
(en)
|
2002-09-30 |
2005-11-24 |
Oncotherapy Science, Inc. |
Method for diagnosing pancreatic cancer
|
|
US20050266443A1
(en)
|
2002-10-11 |
2005-12-01 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
|
WO2004033659A2
(en)
|
2002-10-11 |
2004-04-22 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
|
ATE546528T1
(de)
|
2002-11-13 |
2012-03-15 |
Univ Jefferson |
Zusammensetzungen und verfahren zur diagnose und behandlung von krebs
|
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
WO2004071464A2
(en)
|
2003-02-12 |
2004-08-26 |
Johns Hopkins University School Of Medicine |
Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
|
|
WO2004079013A1
(en)
|
2003-03-03 |
2004-09-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
|
|
US7183384B2
(en)
|
2003-03-06 |
2007-02-27 |
A & G Pharmaceutical, Inc. |
Monoclonal antibody 7H11 reactive with human cancer
|
|
WO2004098377A2
(en)
|
2003-05-02 |
2004-11-18 |
Thomas Jefferson University |
Methods and compositions for diagnosis and therapy of parkin-associated disorders
|
|
WO2006031210A1
(en)
|
2003-05-29 |
2006-03-23 |
Board Of Regents, The University Of Texas Systems |
Jabi as a prognostic marker and a therapeutic target for human cancer
|
|
MXPA05013879A
(es)
|
2003-06-18 |
2006-06-27 |
Genelux Corp |
Virus de la vaccinia recombinantes modificados y otros microorganismos, y usos de los mismos.
|
|
WO2005013901A2
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
US20050037362A1
(en)
|
2003-08-11 |
2005-02-17 |
Eppendorf Array Technologies, S.A. |
Detection and quantification of siRNA on microarrays
|
|
US8412541B2
(en)
|
2003-08-14 |
2013-04-02 |
Edda Technology, Inc. |
Method and system for intelligent qualitative and quantitative analysis for medical diagnosis
|
|
US20050084883A1
(en)
|
2003-08-25 |
2005-04-21 |
The Johns Hopkins University School Of Medicine |
Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
|
|
CN1882702A
(zh)
*
|
2003-09-22 |
2006-12-20 |
罗斯塔英法美蒂克斯有限责任公司 |
用rna干扰进行的协同致死筛选
|
|
EP1670955A2
(en)
*
|
2003-09-22 |
2006-06-21 |
Rosetta Inpharmatics LLC. |
Synthetic lethal screen using rna interference
|
|
WO2005028675A2
(en)
|
2003-09-24 |
2005-03-31 |
Oncotherapy Science, Inc. |
Methods for detecting, diagnosing and treating hepatocellular carcinomas (hcc)
|
|
US20050186589A1
(en)
|
2003-11-07 |
2005-08-25 |
University Of Massachusetts |
Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAi
|
|
US20050164252A1
(en)
|
2003-12-04 |
2005-07-28 |
Yeung Wah Hin A. |
Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell
|
|
EP2299266A1
(en)
|
2003-12-19 |
2011-03-23 |
The Regents of the University of California |
Methods and materials for assessing prostate cancer therapies
|
|
JP4120002B2
(ja)
*
|
2004-01-07 |
2008-07-16 |
愛知県 |
ｍｉＲＮＡを用いた癌の予後判定方法、癌の遺伝子治療ベクター及び癌治療用医薬組成物
|
|
EP1713938A2
(en)
|
2004-02-09 |
2006-10-25 |
Thomas Jefferson University |
DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
|
|
WO2005078096A2
(en)
|
2004-02-09 |
2005-08-25 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
|
CA2556435C
(en)
|
2004-02-13 |
2014-08-12 |
The Rockefeller University |
Anti-microrna oligonucleotide molecules
|
|
EP1723257B1
(en)
|
2004-02-23 |
2019-01-09 |
Erasmus University Medical Center Rotterdam |
Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling
|
|
US7365058B2
(en)
|
2004-04-13 |
2008-04-29 |
The Rockefeller University |
MicroRNA and methods for inhibiting same
|
|
CN101056991A
(zh)
|
2004-04-20 |
2007-10-17 |
基因耐克生物医学制品有限公司 |
检测ncRNA的方法
|
|
CA2566519C
(en)
|
2004-05-14 |
2020-04-21 |
Rosetta Genomics Ltd. |
Micrornas and uses thereof
|
|
EP2471924A1
(en)
|
2004-05-28 |
2012-07-04 |
Asuragen, INC. |
Methods and compositions involving microRNA
|
|
US7635563B2
(en)
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
|
US20060037088A1
(en)
|
2004-08-13 |
2006-02-16 |
Shulin Li |
Gene expression levels as predictors of chemoradiation response of cancer
|
|
DK1797183T3
(da)
|
2004-09-02 |
2012-10-01 |
Univ Yale |
Regulering af onkogener med mikrornas
|
|
US7592441B2
(en)
|
2004-10-04 |
2009-09-22 |
Rosetta Genomics Ltd |
Liver cancer-related nucleic acids
|
|
US7642348B2
(en)
|
2004-10-04 |
2010-01-05 |
Rosetta Genomics Ltd |
Prostate cancer-related nucleic acids
|
|
FR2877350B1
(fr)
|
2004-11-03 |
2010-08-27 |
Centre Nat Rech Scient |
IDENTIFICATION ET UTILISATION DE miRNAs IMPLIQUES DANS LA DIFFERENCIATION DE CELLULES ISSUES D'UNE LEUCEMIE MYELOIDE
|
|
ES2534300T3
(es)
|
2004-11-12 |
2015-04-21 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
|
EP1824872B1
(en)
|
2004-12-14 |
2012-02-08 |
Alnylam Pharmaceuticals Inc. |
Rnai modulation of mll-af4 and uses thereof
|
|
EP1836313A4
(en)
*
|
2004-12-17 |
2010-06-30 |
Veridex Llc |
METHOD FOR ASSESSING PATIENTS WITH AKUTER MYELOIDER LEUKEMIA
|
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
|
US20070099196A1
(en)
|
2004-12-29 |
2007-05-03 |
Sakari Kauppinen |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs
|
|
JP2008528003A
(ja)
|
2005-01-25 |
2008-07-31 |
ロゼッタ インファーマティックス エルエルシー |
小ｒｎａ分子の定量方法
|
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
|
US20070065840A1
(en)
|
2005-03-23 |
2007-03-22 |
Irena Naguibneva |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
|
|
GB2425311A
(en)
|
2005-04-15 |
2006-10-25 |
Ist Superiore Sanita |
Micro RNA against kit protein
|
|
EP2631292A3
(en)
|
2005-04-29 |
2013-11-20 |
The Rockefeller University |
Human microRNAs and methods for inhibiting same
|
|
US20090209621A1
(en)
|
2005-06-03 |
2009-08-20 |
The Johns Hopkins University |
Compositions and methods for decreasing microrna expression for the treatment of neoplasia
|
|
US20070065844A1
(en)
|
2005-06-08 |
2007-03-22 |
Massachusetts Institute Of Technology |
Solution-based methods for RNA expression profiling
|
|
US20060292616A1
(en)
|
2005-06-23 |
2006-12-28 |
U.S. Genomics, Inc. |
Single molecule miRNA-based disease diagnostic methods
|
|
WO2007016548A2
(en)
|
2005-08-01 |
2007-02-08 |
The Ohio State University Research Foundation |
Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
|
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
AU2006279906B2
(en)
|
2005-08-10 |
2012-05-10 |
Alnylam Pharmaceuticals, Inc. |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
US8481505B2
(en)
|
2005-09-12 |
2013-07-09 |
The Ohio State University Research Foundation |
Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
|
|
CA2624531A1
(en)
|
2005-10-05 |
2007-04-19 |
Carlo M. Croce |
Wwox gene, vectors containing the same, and uses in treatment of cancer
|
|
US7390792B2
(en)
|
2005-12-15 |
2008-06-24 |
Board Of Regents, The University Of Texas System |
MicroRNA1 therapies
|
|
AU2007205234B2
(en)
|
2006-01-05 |
2012-07-12 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
|
|
WO2007081680A2
(en)
|
2006-01-05 |
2007-07-19 |
The Ohio State University Research Foundation |
Microrna expression abnormalities in pancreatic endocrine and acinar tumors
|
|
EP2484782B1
(en)
|
2006-01-05 |
2015-11-18 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
CA2636990A1
(en)
|
2006-01-13 |
2007-07-26 |
Battelle Memorial Institute |
Animal model for assessing copd-related diseases
|
|
ES2446362T3
(es)
|
2006-03-20 |
2014-03-07 |
The Ohio State University Research Foundation |
Huellas de microARN durante megacariocipoyesis humana
|
|
WO2007112097A2
(en)
|
2006-03-24 |
2007-10-04 |
Children's Medical Center Corporation |
Novel signature self renewal gene expression programs
|
|
CA3042781C
(en)
|
2006-04-03 |
2021-10-19 |
Roche Innovation Center Copenhagen A/S |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
|
|
CN101472470B
(zh)
|
2006-04-24 |
2013-07-24 |
俄亥俄州立大学研究基金会 |
miR155转基因小鼠中前B细胞增殖和淋巴母细胞性白血病/高度淋巴瘤
|
|
ES2425387T3
(es)
|
2006-07-13 |
2013-10-15 |
The Ohio State University Research Foundation |
Mir-106a para diagnosticar adenocarcinoma de colon de pronóstico de supervivencia pobre
|
|
CA2661354C
(en)
|
2006-08-30 |
2012-12-18 |
The Regents Of The University Of Michigan |
New small molecule inhibitors of mdm2 and the uses thereof
|
|
US20080193943A1
(en)
|
2006-09-05 |
2008-08-14 |
Abbott Laboratories |
Companion diagnostic assays for cancer therapy
|
|
EP2145001A2
(en)
|
2006-09-19 |
2010-01-20 |
Asuragen, Inc. |
Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
|
|
US8071292B2
(en)
|
2006-09-19 |
2011-12-06 |
The Ohio State University Research Foundation |
Leukemia diagnostic methods
|
|
WO2008036741A2
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-200 regulated genes and pathways as targets for therapeutic intervention
|
|
CA2664383C
(en)
|
2006-09-19 |
2017-08-22 |
Asuragen, Inc. |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
|
WO2008054828A2
(en)
|
2006-11-01 |
2008-05-08 |
The Ohio State University Research Foundation |
Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
|
|
US8293684B2
(en)
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
|
WO2008070082A2
(en)
|
2006-12-04 |
2008-06-12 |
The Johns Hopkins University |
Stem-progenitor cell specific micro-ribonucleic acids and uses thereof
|
|
EP2104735A2
(en)
|
2006-12-08 |
2009-09-30 |
Asuragen, INC. |
Mir-21 regulated genes and pathways as targets for therapeutic intervention
|
|
EP2104737B1
(en)
|
2006-12-08 |
2013-04-10 |
Asuragen, INC. |
Functions and targets of let-7 micro rnas
|
|
CN101622348A
(zh)
|
2006-12-08 |
2010-01-06 |
奥斯瑞根公司 |
作为治疗性干预靶标的miR-20调节的基因和途径
|
|
WO2008073919A2
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Mir-20 regulated genes and pathways as targets for therapeutic intervention
|
|
CA2671270A1
(en)
|
2006-12-29 |
2008-07-17 |
Asuragen, Inc. |
Mir-16 regulated genes and pathways as targets for therapeutic intervention
|
|
JP2010516291A
(ja)
|
2007-01-31 |
2010-05-20 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
急性骨髄性白血病（ａｍｌ）の診断、予後及び治療のためのマイクロｒｎａに基づく方法及び組成物
|
|
WO2008104974A2
(en)
|
2007-02-27 |
2008-09-04 |
Rosetta Genomics Ltd. |
Composition and methods for modulating cell proliferation and cell death
|
|
JP5331714B2
(ja)
|
2007-03-16 |
2013-10-30 |
コヴァルクス・アーゲー |
タンパク質複合体をターゲティングする薬物候補の直接質量分析
|
|
CN101688240A
(zh)
|
2007-04-10 |
2010-03-31 |
国立台湾大学 |
通过微rna预测癌症患者的治疗后存活预期
|
|
CN101827941B
(zh)
|
2007-04-30 |
2014-07-16 |
俄亥俄州立大学研究基金会 |
用于区分胰腺癌与正常胰腺功能和/或慢性胰腺炎的方法
|
|
US20090005336A1
(en)
|
2007-05-08 |
2009-01-01 |
Zhiguo Wang |
Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
|
|
US20090131354A1
(en)
|
2007-05-22 |
2009-05-21 |
Bader Andreas G |
miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
US20090232893A1
(en)
|
2007-05-22 |
2009-09-17 |
Bader Andreas G |
miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
WO2008154098A2
(en)
|
2007-06-07 |
2008-12-18 |
Wisconsin Alumni Research Foundation |
Reagents and methods for mirna expression analysis and identification of cancer biomarkers
|
|
AU2008261951A1
(en)
|
2007-06-08 |
2008-12-18 |
Asuragen, Inc. |
miR-34 regulated genes and pathways as targets for therapeutic intervention
|
|
US8465917B2
(en)
|
2007-06-08 |
2013-06-18 |
The Ohio State University Research Foundation |
Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells
|
|
US8053186B2
(en)
|
2007-06-15 |
2011-11-08 |
The Ohio State University Research Foundation |
Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
|
|
EP2173911B1
(en)
|
2007-07-31 |
2014-06-18 |
The Ohio State University Research Foundation |
Methods for reverting methylation by targeting dnmt3a and dnmt3b
|
|
EP2653561B1
(en)
|
2007-08-03 |
2016-03-02 |
The Ohio State University Research Foundation |
Ultraconserved regions encoding ncRNAs
|
|
EP3028708A1
(en)
|
2007-08-22 |
2016-06-08 |
The Ohio State University Research Foundation |
Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
|
|
US20090061424A1
(en)
|
2007-08-30 |
2009-03-05 |
Sigma-Aldrich Company |
Universal ligation array for analyzing gene expression or genomic variations
|
|
EP3138926A3
(en)
|
2007-09-06 |
2017-04-05 |
The Ohio State University Research Foundation |
Microrna signatures in human ovarian cancer
|
|
EP2212440A4
(en)
|
2007-10-11 |
2011-04-06 |
Univ Ohio State Res Found |
METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF ADENOCARCINOMES OF DISHES
|
|
WO2009055773A2
(en)
|
2007-10-26 |
2009-04-30 |
The Ohio State University Research Foundation |
Methods for identifying fragile histidine triad (fhit) interaction and uses thereof
|
|
US20090123933A1
(en)
|
2007-11-12 |
2009-05-14 |
Wake Forest University Health Sciences |
Microrna biomarkers in lupus
|
|
WO2009064590A2
(en)
|
2007-11-12 |
2009-05-22 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
|
|
EP2225396A4
(en)
|
2007-11-30 |
2011-03-02 |
Univ Ohio State Res Found |
PROFILING AND SCREENING OF MICRO-RNA EXPRESSION IN PERIPHERAL BLOOD IN LUNG CANCER
|
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
|
US20090192114A1
(en)
|
2007-12-21 |
2009-07-30 |
Dmitriy Ovcharenko |
miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervention
|
|
AU2009212543B2
(en)
|
2008-02-01 |
2015-07-09 |
The General Hospital Corporation |
Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
|
|
WO2009100430A2
(en)
|
2008-02-08 |
2009-08-13 |
Asuragen, Inc |
miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
|
|
JP2011517932A
(ja)
|
2008-02-28 |
2011-06-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
ヒト慢性リンパ球性白血病（ｃｃｌ）と関連するマイクロｒｎａシグネチャーおよびその使用
|
|
CN102007408A
(zh)
|
2008-02-28 |
2011-04-06 |
俄亥俄州立大学研究基金会 |
与急性髓性白血病(aml)中的细胞遗传学和预后相关的微rna特征及其用途
|
|
JP5662166B2
(ja)
|
2008-02-28 |
2015-01-28 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイションＴｈｅ Ｏｈｉｏ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ |
胃癌の診断、予後診断及び治療のためのマイクロｒｎａに基づいた方法及び組成物
|
|
US20110054009A1
(en)
|
2008-02-28 |
2011-03-03 |
The Ohio State University Research Foundation |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
|
|
US20090233297A1
(en)
|
2008-03-06 |
2009-09-17 |
Elizabeth Mambo |
Microrna markers for recurrence of colorectal cancer
|
|
US20090253780A1
(en)
|
2008-03-26 |
2009-10-08 |
Fumitaka Takeshita |
COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
|
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
|
WO2009149418A2
(en)
|
2008-06-06 |
2009-12-10 |
Asuragen, Inc. |
Novel compositions for the in vivo delivery of rnai agents
|
|
WO2009152300A1
(en)
|
2008-06-11 |
2009-12-17 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Use of mir-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
|
|
CA2734179A1
(en)
|
2008-08-12 |
2010-02-18 |
The Ohio State University Research Foundation |
Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma
|
|
AU2009316584A1
(en)
|
2008-11-21 |
2010-05-27 |
The Ohio State University Research Foundation |
Tcl1 as a transcriptional regulator
|
|
WO2010065156A1
(en)
|
2008-12-05 |
2010-06-10 |
The Ohio State University Research Foundation |
Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer
|
|
JP2012518997A
(ja)
|
2009-02-26 |
2012-08-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
喫煙未経験者におけるマイクロｒｎａ、ならびに関連する材料および方法
|